Tyro3 knockdown studies in tumour xenograft models have shown a role for Tyro3 in tumour progression, as well as the association of Tyro3 expression with poor prognosis in, amongst others, colorectal, hepatocellular, breast, and bladder cancers [28,36]. The gene discussed is TYRO3; the disease is neoplasm.